Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
US7244751B2 · kind B2 · utility
13Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2004 |
| Grant date | Jul 17, 2007 |
| Priority date | — |
| Expiry date | Jun 20, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C237/42
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is related to the preparation and pharmaceutical use of novel benzamide derivatives as defined in the specification of formula (I) as histone deacetylase inhibitors (HDACI), their preparations and the methods of using these compounds or their pharmaceutically acceptable salt in the treatment of cell proliferative diseases, e.g. cancer and psoriasis
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.